Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2+ breast cancer

AB Hanker, MV Estrada, G Bianchini, PD Moore, J Zhao, F Cheng, JP Koch, L Gianni, DR Tyson, V Sanchez, BN Rexer, ME Sánders, Z Zhao, TP Stricker, CL Arteaga

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2+ breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences